Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Abracadabra!

<< Previous

Bullboard Posts

Next >>

Comment by Hcallahan44on Nov 23, 2022 11:09am

123 Views

Post# 35121935

RE:RE:RE:RE:RE:Abracadabra!

You pumpers are all hopelessly paranoid....maybeTB is like me another frustrated owner who is sick of listening to you and noteable and canada blather on for decades about the prospects here....i for one am glad to see folks who actually understand that this stock is mostly Coffee's candy machine....make promises...then hit the ATM and steal our cash......sick sick sick of it

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments